{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:52:51Z","timestamp":1771300371922,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11060-020-03420-z","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T09:03:16Z","timestamp":1613898196000},"page":"403-413","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Fluorescence guided surgery for pituitary adenomas"],"prefix":"10.1007","volume":"151","author":[{"given":"Nikita","family":"Lakomkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie J.","family":"Van Gompel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalmon D.","family":"Post","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve S.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Y. K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8615-6644","authenticated-orcid":false,"given":"Constantinos G.","family":"Hadjipanayis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,21]]},"reference":[{"key":"3420_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cncr.20412","volume":"101","author":"S Ezzat","year":"2004","unstructured":"Ezzat S, Asa SL, Couldwell WT et al (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101:613\u2013619. https:\/\/doi.org\/10.1002\/cncr.20412","journal-title":"Cancer"},{"key":"3420_CR2","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1210\/jcem.84.11.6202","volume":"84","author":"PU Freda","year":"1999","unstructured":"Freda PU, Wardlaw SL (1999) Diagnosis and treatment of pituitary tumors. J Clin Endocrinol Metab 84:3859\u20133866. https:\/\/doi.org\/10.1210\/jcem.84.11.6202","journal-title":"J Clin Endocrinol Metab"},{"key":"3420_CR3","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1158\/1078-0432.CCR-17-2206","volume":"24","author":"MP Salomon","year":"2018","unstructured":"Salomon MP, Wang X, Marzese DM et al (2018) The epigenomic landscape of pituitary adenomas reveals specific alterations and differentiates among acromegaly, cushing\u2019s disease and endocrine-inactive subtypes. Clin Cancer Res 24:4126\u20134136. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2206","journal-title":"Clin Cancer Res"},{"key":"3420_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1210\/jcem.84.2.5505","volume":"84","author":"F Brucker-Davis","year":"1999","unstructured":"Brucker-Davis F, Oldfield EH, Skarulis MC et al (1999) Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84:476\u2013486. https:\/\/doi.org\/10.1210\/jcem.84.2.5505","journal-title":"J Clin Endocrinol Metab"},{"key":"3420_CR5","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1210\/jc.2014-2362","volume":"99","author":"G Ntali","year":"2014","unstructured":"Ntali G, Capatina C, Grossman A, Karavitaki N (2014) Functioning gonadotroph adenomas. J Clin Endocrinol Metab 99:4423\u20134433. https:\/\/doi.org\/10.1210\/jc.2014-2362","journal-title":"J Clin Endocrinol Metab"},{"key":"3420_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.14797\/mdcj-13-2-64","volume":"13","author":"MD Sharma","year":"2017","unstructured":"Sharma MD, Nguyen AV, Brown S, Robbins RJ (2017) Cardiovascular disease in acromegaly. Methodist DeBakey Cardiovasc J 13:64\u201367. https:\/\/doi.org\/10.14797\/mdcj-13-2-64","journal-title":"Methodist DeBakey Cardiovasc J"},{"issue":"4","key":"3420_CR7","doi-asserted-by":"publisher","first-page":"M133","DOI":"10.1530\/EJE-15-0354","volume":"173","author":"F Ferrau","year":"2015","unstructured":"Ferrau F, Korbonits M (2015) Metabolic comorbidities in Cushing\u2019s syndrome. Eur J Endocrinol 173(4):M133\u2013M157","journal-title":"Eur J Endocrinol"},{"key":"3420_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s11102-019-00960-0","volume":"22","author":"D Esposito","year":"2019","unstructured":"Esposito D, Olsson DS, Ragnarsson O et al (2019) Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management. Pituitary 22:422\u2013434. https:\/\/doi.org\/10.1007\/s11102-019-00960-0","journal-title":"Pituitary"},{"key":"3420_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/02688690050175229","volume":"14","author":"H-D Jho","year":"2000","unstructured":"Jho H-D AA (2000) Endoscopic transsphenoidal pituitary surgery: various surgical techniques and recommended steps for procedural transition. Br J Neurosurg 14:432\u2013440. https:\/\/doi.org\/10.1080\/02688690050175229","journal-title":"Br J Neurosurg"},{"key":"3420_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3171\/jns.1997.87.1.0044","volume":"87","author":"H-D Jho","year":"1997","unstructured":"Jho H-D, Carrau RL (1997) Endoscopic endonasal transsphenoidal surgery: experience with 50 patients. J Neurosurg 87:44\u201351. https:\/\/doi.org\/10.3171\/jns.1997.87.1.0044","journal-title":"J Neurosurg"},{"key":"3420_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/s0090-3019(02)00705-x","volume":"57","author":"CH Alleyne","year":"2002","unstructured":"Alleyne CH, Barrow DL, Oyesiku NM (2002) Combined transsphenoidal and pterional craniotomy approach to giant pituitary tumors. Surg Neurol 57:380\u2013390. https:\/\/doi.org\/10.1016\/s0090-3019(02)00705-x discussion 390.","journal-title":"Surg Neurol"},{"key":"3420_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1148\/radiology.215.2.r00ap18463","volume":"215","author":"J-P Cottier","year":"2000","unstructured":"Cottier J-P, Destrieux C, Brunereau L et al (2000) Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology 215:463\u2013469. https:\/\/doi.org\/10.1148\/radiology.215.2.r00ap18463","journal-title":"Radiology"},{"key":"3420_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2214\/ajr.146.2.257","volume":"146","author":"J Ahmadi","year":"1986","unstructured":"Ahmadi J, North C, Segall H et al (1986) Cavernous sinus invasion by pituitary adenomas. Am J Roentgenol 146:257\u2013262. https:\/\/doi.org\/10.2214\/ajr.146.2.257","journal-title":"Am J Roentgenol"},{"key":"3420_CR14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2214\/ajr.151.4.799","volume":"151","author":"G Scotti","year":"1988","unstructured":"Scotti G, Yu C, Dillon W et al (1988) MR imaging of cavernous sinus involvement by pituitary adenomas. Am J Roentgenol 151:799\u2013806. https:\/\/doi.org\/10.2214\/ajr.151.4.799","journal-title":"Am J Roentgenol"},{"key":"3420_CR15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3174\/ajnr.A2364","volume":"32","author":"X Chen","year":"2011","unstructured":"Chen X, Dai J, Ai L et al (2011) Clival invasion on multi-detector CT in 390 pituitary macroadenomas: correlation with sex, subtype and rates of operative complication and recurrence. Am J Neuroradiol 32:785\u2013789. https:\/\/doi.org\/10.3174\/ajnr.A2364","journal-title":"Am J Neuroradiol"},{"key":"3420_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/2042018816687240","volume":"8","author":"A Prete","year":"2017","unstructured":"Prete A, Corsello SM, Salvatori R (2017) Current best practice in the management of patients after pituitary surgery. Ther Adv Endocrinol Metab 8:33\u201348. https:\/\/doi.org\/10.1177\/2042018816687240","journal-title":"Ther Adv Endocrinol Metab"},{"key":"3420_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.nec.2019.05.002","volume":"30","author":"SS Cho","year":"2019","unstructured":"Cho SS, Lee JYK (2019) Intraoperative fluorescent visualization of pituitary adenomas. Neurosurg Clin N Am 30:401\u2013412. https:\/\/doi.org\/10.1016\/j.nec.2019.05.002","journal-title":"Neurosurg Clin N Am"},{"key":"3420_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fsurg.2019.00030","volume":"6","author":"N Lakomkin","year":"2019","unstructured":"Lakomkin N, Hadjipanayis CG (2019) The use of spectroscopy handheld tools in brain tumor surgery: current evidence and techniques. Front Surg 6:30. https:\/\/doi.org\/10.3389\/fsurg.2019.00030","journal-title":"Front Surg"},{"key":"3420_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s11060-018-03062-2","volume":"141","author":"SW Chang","year":"2019","unstructured":"Chang SW, Donoho DA, Zada G (2019) Use of optical fluorescence agents during surgery for pituitary adenomas: current state of the field. J Neurooncol 141:585\u2013593. https:\/\/doi.org\/10.1007\/s11060-018-03062-2","journal-title":"J Neurooncol"},{"key":"3420_CR20","doi-asserted-by":"publisher","first-page":"E539","DOI":"10.1227\/NEU.0000000000001385","volume":"79","author":"J Sheehan","year":"2016","unstructured":"Sheehan J, Lee C-C, Bodach ME et al (2016) Congress of neurological surgeons systematic review and evidence-based guideline for the management of patients with residual or recurrent nonfunctioning pituitary adenomas. Neurosurgery 79:E539\u2013E540. https:\/\/doi.org\/10.1227\/NEU.0000000000001385","journal-title":"Neurosurgery"},{"key":"3420_CR21","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3171\/2014.6.JNS131994","volume":"121","author":"S Berkmann","year":"2014","unstructured":"Berkmann S, Schlaffer S, Nimsky C et al (2014) Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma. J Neurosurg 121:1166\u20131175. https:\/\/doi.org\/10.3171\/2014.6.JNS131994","journal-title":"J Neurosurg"},{"key":"3420_CR22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/jso.25154","volume":"118","author":"N Lakomkin","year":"2018","unstructured":"Lakomkin N, Hadjipanayis CG (2018) Fluorescence-guided surgery for high-grade gliomas. J Surg Oncol 118:356\u2013361. https:\/\/doi.org\/10.1002\/jso.25154","journal-title":"J Surg Oncol"},{"key":"3420_CR23","first-page":"20","volume":"55","author":"J-C Tonn","year":"2008","unstructured":"Tonn J-C, Stummer W (2008) Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls. Clin Neurosurg 55:20\u201326","journal-title":"Clin Neurosurg"},{"key":"3420_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10143-015-0695-2","volume":"39","author":"N Ferraro","year":"2016","unstructured":"Ferraro N, Barbarite E, Albert TR et al (2016) The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review. Neurosurg Rev 39:545\u2013555. https:\/\/doi.org\/10.1007\/s10143-015-0695-2","journal-title":"Neurosurg Rev"},{"key":"3420_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11060-019-03109-y","volume":"141","author":"CG Hadjipanayis","year":"2019","unstructured":"Hadjipanayis CG, Stummer W, Sheehan JP (2019) 5-ALA fluorescence-guided surgery of CNS tumors. J Neurooncol 141:477\u2013478. https:\/\/doi.org\/10.1007\/s11060-019-03109-y","journal-title":"J Neurooncol"},{"key":"3420_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","volume":"7","author":"W Stummer","year":"2006","unstructured":"Stummer W, Pichlmeier U, Meinel T et al (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392\u2013401. https:\/\/doi.org\/10.1016\/S1470-2045(06)70665-9","journal-title":"Lancet Oncol"},{"key":"3420_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0378-4347(99)00121-8","volume":"729","author":"ED Moody","year":"1999","unstructured":"Moody ED, Viskari PJ, Colyer CL (1999) Non-covalent labeling of human serum albumin with indocyanine green: a study by capillary electrophoresis with diode laser-induced fluorescence detection. J Chromatogr B 729:55\u201364. https:\/\/doi.org\/10.1016\/s0378-4347(99)00121-8","journal-title":"J Chromatogr B"},{"key":"3420_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2019.00011","author":"SS Cho","year":"2019","unstructured":"Cho SS, Salinas R, Lee JYK (2019) Indocyanine-green for fluorescence-guided surgery of brain tumors: evidence, techniques, and practical experience. Front Surg.https:\/\/doi.org\/10.3389\/fsurg.2019.00011","journal-title":"Front Surg"},{"key":"3420_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","volume":"63","author":"J Fang","year":"2011","unstructured":"Fang J, Nakamura H, Maeda H (2011) The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63:136\u2013151. https:\/\/doi.org\/10.1016\/j.addr.2010.04.009","journal-title":"Adv Drug Deliv Rev"},{"key":"3420_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/ijc.30102","volume":"139","author":"N Onda","year":"2016","unstructured":"Onda N, Kimura M, Yoshida T, Shibutani M (2016) Preferential tumor cellular uptake and retention of indocyanine green for in vivo tumor imaging. Int J Cancer 139:673\u2013682. https:\/\/doi.org\/10.1002\/ijc.30102","journal-title":"Int J Cancer"},{"key":"3420_CR31","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ymthe.2017.10.016","volume":"26","author":"JD Predina","year":"2018","unstructured":"Predina JD, Newton AD, Connolly C et al (2018) Identification of a folate receptor-targeted near-infrared molecular contrast agent to localize pulmonary adenocarcinomas. Mol Ther 26:390\u2013403. https:\/\/doi.org\/10.1016\/j.ymthe.2017.10.016","journal-title":"Mol Ther"},{"key":"3420_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-26683-z","volume":"8","author":"L Xing","year":"2018","unstructured":"Xing L, Xu Y, Sun K et al (2018) Identification of a peptide for folate receptor alpha by phage display and its tumor targeting activity in ovary cancer xenograft. Sci Rep 8:1\u201313. https:\/\/doi.org\/10.1038\/s41598-018-26683-z","journal-title":"Sci Rep"},{"key":"3420_CR33","first-page":"4218","volume":"63","author":"C-O Evans","year":"2003","unstructured":"Evans C-O, Reddy P, Brat DJ et al (2003) Differential expression of folate receptor in pituitary adenomas. Cancer Res 63:4218\u20134224","journal-title":"Cancer Res"},{"key":"3420_CR34","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1210\/en.2013-1182","volume":"154","author":"M Lee","year":"2013","unstructured":"Lee M, Pellegata NS (2013) Folate receptor-mediated drug targeting: a possible strategy for nonfunctioning pituitary adenomas? Endocrinology 154:1387\u20131389. https:\/\/doi.org\/10.1210\/en.2013-1182","journal-title":"Endocrinology"},{"key":"3420_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2019.00049","author":"J Falco","year":"2019","unstructured":"Falco J, Cavallo C, Vetrano IG et al (2019) Fluorescein application in cranial and spinal tumors enhancing at preoperative MRI and operated with a dedicated filter on the surgical microscope: preliminary results in 279 patients enrolled in the FLUOCERTUM prospective study. Front Surg.https:\/\/doi.org\/10.3389\/fsurg.2019.00049","journal-title":"Front Surg"},{"key":"3420_CR36","doi-asserted-by":"publisher","first-page":"690","DOI":"10.23736\/S0390-5616.18.04480-6","volume":"62","author":"C Cavallo","year":"2018","unstructured":"Cavallo C, De Laurentis C, Vetrano IG et al (2018) The utilization of fluorescein in brain tumor surgery: a systematic review. J Neurosurg Sci 62:690\u2013703. https:\/\/doi.org\/10.23736\/S0390-5616.18.04480-6","journal-title":"J Neurosurg Sci"},{"key":"3420_CR37","doi-asserted-by":"publisher","first-page":"e0161364","DOI":"10.1371\/journal.pone.0161364","volume":"11","author":"A Nemes","year":"2016","unstructured":"Nemes A, Fortmann T, Poeschke S et al (2016) 5-ALA fluorescence in native pituitary adenoma cell lines: resection control and basis for photodynamic therapy (PDT)? PLoS ONE 11:e0161364. https:\/\/doi.org\/10.1371\/journal.pone.0161364","journal-title":"PLoS ONE"},{"key":"3420_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pdpdt.2016.02.006","volume":"14","author":"LM Neumann","year":"2016","unstructured":"Neumann LM, Beseoglu K, Slotty PJ et al (2016) Efficacy of 5-aminolevulinic acid based photodynamic therapy in pituitary adenomas-experimental study on rat and human cell cultures. Photodiagnosis Photodyn Ther 14:77\u201383. https:\/\/doi.org\/10.1016\/j.pdpdt.2016.02.006","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"3420_CR39","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2013.12.FOCUS13464","volume":"36","author":"S Marbacher","year":"2014","unstructured":"Marbacher S, Klinger E, Schwyzer L et al (2014) Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases. Neurosurg Focus 36:E10. https:\/\/doi.org\/10.3171\/2013.12.FOCUS13464","journal-title":"Neurosurg Focus"},{"key":"3420_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11060-009-9820-9","volume":"92","author":"MS Eljamel","year":"2009","unstructured":"Eljamel MS, Leese G, Moseley H (2009) Intraoperative optical identification of pituitary adenomas. J Neurooncol 92:417\u2013421. https:\/\/doi.org\/10.1007\/s11060-009-9820-9","journal-title":"J Neurooncol"},{"key":"3420_CR41","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3171\/2017.2.JNS163191","volume":"129","author":"JYK Lee","year":"2018","unstructured":"Lee JYK, Cho SS, Zeh R et al (2018) Folate receptor overexpression can be visualized in real time during pituitary adenoma endoscopic transsphenoidal surgery with near-infrared imaging. J Neurosurg 129:390\u2013403. https:\/\/doi.org\/10.3171\/2017.2.JNS163191","journal-title":"J Neurosurg"},{"key":"3420_CR42","doi-asserted-by":"publisher","DOI":"10.3171\/2018.7.JNS181642","author":"SS Cho","year":"2018","unstructured":"Cho SS, Jeon J, Buch L et al (2018) Intraoperative near-infrared imaging with receptor-specific versus passive delivery of fluorescent agents in pituitary adenomas. J Neurosurg.https:\/\/doi.org\/10.3171\/2018.7.JNS181642","journal-title":"J Neurosurg"},{"key":"3420_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/ons\/opy034","volume":"16","author":"SS Cho","year":"2019","unstructured":"Cho SS, Zeh R, Pierce JT et al (2019) Folate receptor near-infrared optical imaging provides sensitive and specific intraoperative visualization of nonfunctional pituitary adenomas. Oper Neurosurg 16:59\u201370. https:\/\/doi.org\/10.1093\/ons\/opy034","journal-title":"Oper Neurosurg"},{"key":"3420_CR44","doi-asserted-by":"publisher","DOI":"10.3171\/2019.1.JNS181512","author":"S Romano-Feinholz","year":"2019","unstructured":"Romano-Feinholz S, Alcocer-Barradas V, Ben\u00edtez-Gasca A et al (2019) Hybrid fluorescein-guided surgery for pituitary adenoma resection: a pilot study. J Neurosurg.https:\/\/doi.org\/10.3171\/2019.1.JNS181512","journal-title":"J Neurosurg"},{"key":"3420_CR45","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00701-018-03778-0","volume":"161","author":"K Amano","year":"2019","unstructured":"Amano K, Aihara Y, Tsuzuki S et al (2019) Application of indocyanine green fluorescence endoscopic system in transsphenoidal surgery for pituitary tumors. Acta Neurochir (Wien) 161:695\u2013706. https:\/\/doi.org\/10.1007\/s00701-018-03778-0","journal-title":"Acta Neurochir (Wien)"},{"key":"3420_CR46","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s11102-014-0620-7","volume":"18","author":"N Sandow","year":"2015","unstructured":"Sandow N, Klene W, Elbelt U et al (2015) Intraoperative indocyanine green videoangiography for identification of pituitary adenomas using a microscopic transsphenoidal approach. Pituitary 18:613\u2013620. https:\/\/doi.org\/10.1007\/s11102-014-0620-7","journal-title":"Pituitary"},{"key":"3420_CR47","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3171\/2012.1.JNS11601","volume":"116","author":"ZN Litvack","year":"2012","unstructured":"Litvack ZN, Zada G, Laws ER (2012) Indocyanine green fluorescence endoscopy for visual differentiation of pituitary tumor from surrounding structures: Clinical article. J Neurosurg 116:935\u2013941. https:\/\/doi.org\/10.3171\/2012.1.JNS11601","journal-title":"J Neurosurg"},{"key":"3420_CR48","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1227\/NEU.0000000000001328","volume":"12","author":"MJT Verstegen","year":"2016","unstructured":"Verstegen MJT, Tummers QRJG, Schutte PJ et al (2016) Intraoperative identification of a normal pituitary gland and an adenoma using near-infrared fluorescence imaging and low-dose indocyanine green. Oper Neurosurg 12:260\u2013268. https:\/\/doi.org\/10.1227\/NEU.0000000000001328","journal-title":"Oper Neurosurg"},{"key":"3420_CR49","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3171\/2014.9.JNS14599","volume":"122","author":"T Hide","year":"2015","unstructured":"Hide T, Yano S, Shinojima N, Kuratsu J (2015) Usefulness of the indocyanine green fluorescence endoscope in endonasal transsphenoidal surgery. J Neurosurg 122:1185\u20131192. https:\/\/doi.org\/10.3171\/2014.9.JNS14599","journal-title":"J Neurosurg"},{"key":"3420_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/ons\/opy213","volume":"17","author":"JW Jeon","year":"2019","unstructured":"Jeon JW, Cho SS, Nag S et al (2019) Near-infrared optical contrast of skull base tumors during endoscopic endonasal surgery. Oper Neurosurg 17:32\u201342. https:\/\/doi.org\/10.1093\/ons\/opy213","journal-title":"Oper Neurosurg"},{"key":"3420_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fsurg.2016.00055","volume":"3","author":"E Belykh","year":"2016","unstructured":"Belykh E, Martirosyan NL, Yagmurlu K et al (2016) Intraoperative fluorescence imaging for personalized brain tumor resection: current state and future directions. Front Surg 3:55. https:\/\/doi.org\/10.3389\/fsurg.2016.00055","journal-title":"Front Surg"},{"key":"3420_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3171\/2011.2.JNS101451","volume":"115","author":"PA Vald\u00e9s","year":"2011","unstructured":"Vald\u00e9s PA, Leblond F, Kim A et al (2011) Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg 115:11. https:\/\/doi.org\/10.3171\/2011.2.JNS101451","journal-title":"J Neurosurg"},{"key":"3420_CR53","doi-asserted-by":"publisher","first-page":"899","DOI":"10.2967\/jnumed.107.049478","volume":"49","author":"RE Fisher","year":"2008","unstructured":"Fisher RE, Siegel BA, Edell SL et al (2008) Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors. J Nucl Med Off Publ Soc Nucl Med 49:899\u2013906. https:\/\/doi.org\/10.2967\/jnumed.107.049478","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"3420_CR54","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.3748\/wjg.v24.i27.2921","volume":"24","author":"GL Baiocchi","year":"2018","unstructured":"Baiocchi GL, Diana M, Boni L (2018) Indocyanine green-based fluorescence imaging in visceral and hepatobiliary and pancreatic surgery: state of the art and future directions. World J Gastroenterol 24:2921\u20132930. https:\/\/doi.org\/10.3748\/wjg.v24.i27.2921","journal-title":"World J Gastroenterol"},{"key":"3420_CR55","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11307-017-1107-5","volume":"20","author":"SS Cho","year":"2018","unstructured":"Cho SS, Zeh R, Pierce JT et al (2018) Comparison of near-infrared imaging camera systems for intracranial tumor detection. Mol Imaging Biol 20:213\u2013220. https:\/\/doi.org\/10.1007\/s11307-017-1107-5","journal-title":"Mol Imaging Biol"},{"key":"3420_CR56","doi-asserted-by":"publisher","first-page":"80901","DOI":"10.1117\/1.JBO.21.8.080901","volume":"21","author":"AV DSouza","year":"2016","unstructured":"DSouza AV, Lin H, Henderson ER et al (2016) Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging. J Biomed Opt 21:80901. https:\/\/doi.org\/10.1117\/1.JBO.21.8.080901","journal-title":"J Biomed Opt"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03420-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-020-03420-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03420-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T08:06:26Z","timestamp":1613981186000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-020-03420-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["3420"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03420-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"5 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Constantinos Hadjipanayis is a consultant for NXDC and Synaptive Medical Inc. He will receive royalties from NXDC. He has also received speaker fees by Carl Zeiss and Leica.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}